SFJ Pharmaceuticals X, LTD.
1 clinical trials · Sponsor
◉ Watch SFJ Pharmaceuticals X, LTD.
| Record | Firm | Date |
|---|---|---|
| Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer. (NCT03688230) | SFJ Pharmaceuticals X, LTD. | 2019-04-01 |
Track SFJ Pharmaceuticals X, LTD. automatically
Every clearance here is in the API, with alerts when new ones post.